Ziopharm oncology
Ziopharm oncology is a biotechnology company that acquires, develops, and commercializes cancer therapies.
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed Ziopharm oncology Information
Geographic Data
Address:
City: New York
State: New York
Zip:
Country: United States
Financial Info
Stage:
post ipo equity
Raised Last:
$8M
Raised Total:$278M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Ziopharm Oncology is a biotechnology company employing a novel gene expression and control technology to deliver DNA for the treatment of cancer. ZIOPHARM&s;s technology platform employs Intrexon Corporation&s;s RheoSwitch Therapeutic System® to turn on and off and precisely modulate gene expression at the cancer site in order to improve the therapeutic index. This technology is currently being evaluated in Phase 2 clinical studies of the immune system cytokine interleukin-12 for the treatment of breast cancer and advanced melanoma. Multiple new INDs for new targets using similar technology are expected in 2014 and 2015. ZIOPHARM is also developing novel small molecules as potential cancer therapeutics.
Contact Phone:
Contact Email:
Ziopharm oncology went public on 11/11/2005 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/11/2005
Ticker Symbol:
ZIOP
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
